Basis: Trailing twelve months (TTM net income over TTM revenue). Source: stored company filings and market data; unavailable inputs remain N/A.
The net profit margin is 0.00% as of the fiscal period ended Tuesday, June 30, 2026.
Reported quarterly profit margin; no daily interpolation. Q2 FY2026 (2026-06-30): 0.00%.
NET PROFIT MARGIN
0.00%
NET PROFIT MARGIN AVG TTM
0.00%
NET PROFIT MARGIN AVG 3Y
0.00%
NET PROFIT MARGIN AVG 5Y
0.00%
NET PROFIT MARGIN AVG 10Y
-18823.08%
NET PROFIT MARGIN AVG 15Y
-7035.66%
NET PROFIT MARGIN AVG 20Y
-2519.71%
CURRENT VS TTM AVG
N/A
CURRENT VS 3Y AVG
N/A
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
+100.00%
CURRENT VS 15Y AVG
+100.00%
CURRENT VS 20Y AVG
+100.00%
SECTOR MEDIAN · HEALTHCARE
-0.26%
median of 863 covered companies
CURRENT VS SECTOR MEDIAN
+100.00%
vs the sector median at left
ProMIS Neurosciences, Inc.
Market Cap
$82.59M
Net Profit Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$82.53M
Net Profit Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$82.47M
Net Profit Margin
-7884.06%
TTM Avg
-7191.86%
3Y Avg
-8225.67%
5Y Avg
-7676.39%
Market Cap
$82.29M
Net Profit Margin
57.57%
TTM Avg
-58.69%
3Y Avg
-51.95%
5Y Avg
-56.60%
Market Cap
$81.22M
Net Profit Margin
-1168.20%
TTM Avg
-1464.39%
3Y Avg
-946.48%
5Y Avg
-672.82%
Market Cap
$81.20M
Net Profit Margin
-430.43%
TTM Avg
-446.97%
3Y Avg
-347.08%
5Y Avg
-386.84%
Market Cap
$84.13M
Net Profit Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$80.30M
Net Profit Margin
-4560.82%
TTM Avg
-1001.79%
3Y Avg
-692.03%
5Y Avg
-1554.36%
Market Cap
$79.61M
Net Profit Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
| NAME | MARKET CAP | NET PROFIT MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| ProMIS Neurosciences, Inc. (PMN) | $82.59M | 0.00% | 0.00% | 0.00% | 0.00% |
| Telomir Pharmaceuticals, Inc. Common Stock (TELO)vs › | $82.53M | 0.00% | 0.00% | 0.00% | 0.00% |
| Cardiff Oncology, Inc. (CRDF)vs › | $82.47M | -7884.06% | -7191.86% | -8225.67% | -7676.39% |
| LENSAR Inc (LNSR)vs › | $82.29M | 57.57% | -58.69% | -51.95% | -56.60% |
| MediciNova, Inc. (MNOV)vs › | $81.22M | -1168.20% | -1464.39% | -946.48% | -672.82% |
| Nutriband Inc. (NTRB)vs › | $81.20M | -430.43% | -446.97% | -347.08% | -386.84% |
| Cognition Therapeutics, Inc. (CGTX)vs › | $84.13M | 0.00% | 0.00% | 0.00% | 0.00% |
| Humacyte, Inc. (HUMA)vs › | $80.30M | -4560.82% | -1001.79% | -692.03% | -1554.36% |
| Acrivon Therapeutics, Inc. Common Stock (ACRV)vs › | $79.61M | 0.00% | 0.00% | 0.00% | 0.00% |
| PMV Pharmaceuticals, Inc. (PMVP)vs › | $85.86M | 0.00% | 0.00% | 0.00% | 0.00% |
Operating Margin
0.0%
Net Profit Margin
0.0%
Net Profit Margin = Net Income / Revenue
Net profit margin is the percentage of revenue that becomes net income after all expenses, taxes, and interest.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | NET PROFIT MARGIN |
|---|---|
| 2026-06-30 | 0.00% |
| 2026-03-31 | 0.00% |
| 2025-12-31 | 0.00% |
| 2025-09-30 | 0.00% |
| 2025-06-30 | 0.00% |
| 2025-03-31 | 0.00% |
| 2024-12-31 | 0.00% |
| 2024-09-30 | 0.00% |
| 2024-06-30 | 0.00% |
| 2024-03-31 | 0.00% |
| 2023-12-31 | 0.00% |
| 2023-09-30 | 0.00% |
| 2023-06-30 | 0.00% |
| 2023-03-31 | 0.00% |
| 2022-12-31 | 233994.34% |
| 2022-09-30 | 0.00% |
| 2022-06-30 | 0.00% |
| 2022-03-31 | -54626.80% |
| 2021-12-31 | -55505.90% |
| 2021-09-30 | -18861.11% |
| 2021-06-30 | 0.00% |
| 2021-03-31 | 0.00% |
| 2020-12-31 | 0.00% |
| 2020-09-30 | 0.00% |
| 2020-06-30 | -105445.24% |
| 2020-03-31 | 0.00% |
| 2019-12-31 | -120918.30% |
| 2019-09-30 | -19709144.28% |
| 2019-06-30 | -9568232.68% |
| 2019-03-31 | 9005648.37% |
| 2018-12-31 | -756008.84% |
| 2018-09-30 | -1107216.71% |
| 2018-06-30 | 0.00% |
| 2018-03-31 | -41002397.63% |
| 2017-12-31 | -367658.52% |
| 2017-09-30 | -17837.92% |
| 2017-06-30 | -4929965.09% |
| 2017-03-31 | -210320.21% |
| 2016-12-31 | -598119.51% |
| 2016-09-30 | 0.00% |
| 2016-06-30 | 0.00% |
| 2016-03-31 | -26956.96% |
| 2015-12-31 | 45435.88% |
| 2015-09-30 | -6909.15% |
| 2015-06-30 | -33206.18% |
| 2015-03-31 | -3754.43% |
| 2014-12-31 | -818.98% |
| 2014-09-30 | -1200.21% |
| 2014-06-30 | -677.14% |
| 2014-03-31 | -1447.65% |
| 2013-12-31 | -1223.64% |
| 2013-09-30 | -1863.97% |
| 2013-06-30 | -1676.52% |
| 2013-03-31 | -1976.22% |
| 2012-12-31 | -2231.33% |
| 2012-09-30 | -74529.83% |
| 2012-06-30 | -36322.29% |
| 2012-03-31 | -35918.68% |
| 2011-12-31 | -3941.48% |
| 2011-09-30 | -50.19% |
| 2011-06-30 | -1611.24% |
| 2011-03-31 | -1386.14% |
| 2010-12-31 | -8061.91% |
| 2010-09-30 | 7.61% |
| 2010-06-30 | -7041.50% |
| 2010-03-31 | -4126.42% |
| 2009-12-31 | -1610.98% |
| 2009-09-30 | -3358.77% |
| 2009-06-30 | -2835.86% |
| 2009-03-31 | -2528.90% |
| 2008-12-31 | -1876.96% |
| 2008-09-30 | -1960.75% |
| 2008-06-30 | -2117.38% |
| 2008-03-31 | -1877.34% |
| 2007-12-31 | -12501.05% |
| 2007-09-30 | -1608.46% |
| 2007-06-30 | -1321.20% |
| 2007-03-31 | -2194.88% |
| 2006-12-31 | -1305.89% |
| 2006-09-30 | -1364.30% |
| 2006-06-30 | -1593.16% |
| 2006-03-31 | -5901.93% |
| 2005-12-31 | -2978.21% |
| 2005-09-30 | -35603.89% |
| 2005-06-30 | -22089.75% |
